Table 1.

Characteristics of Included Studies

Author, YearCountryPatients StudiedMean or median age% MaleDefinition of Bad OutcomeMortality Rate, %
Yu, 202032ChinaAdults with COVID-19 from 27 hospitals in Jiangsu Province with a CT scan48 (median)53.0Composite of ICU admission, acute respiratory failure occurrence, or shock during hospitalization15.0
Wang, 202033ChinaAdults with COVID-19 who were discharged from 2 hospitals (Wuhan and Hubei Province)51 (median)53.3Death17.8
Chen, 202034ChinaAdults with COVID-19 classified as moderately, severely or critically ill in 1 hospital in Wuhan68 (median)62.4Death41.2
Zhou, 202035ChinaAdults with COVID-19 who had been discharged or died in 2 Wuhan hospitals56 (median)62.3Death28.0
Liu, 202036ChinaAdults with COVID-19 pneumonia in 3 tertiary hospitals in Wuhan38 (median)50Clinical deterioration14.1
Liang, 202019ChinaAdults with COVID-19 from 575 hospitals in 31 regions of China48.9 (mean)57.3Composite of admission to ICU, invasive ventilation, death3.2
Xie, 202037ChinaAdults with COVID-19 who had been discharged from or died in 2 hospitals in Wuhan62 (median)53.8Death50.5
Yan, 202038ChinaAdults with COVID-19 in 1 hospital in Wuhan58.83 (mean)58.7Death46.4
Cao, 202039ChinaAdults with COVID-19 in 1 hospital in Shanghai50.1 (mean)51Admission to ICUNR
Hu, 202040ChinaAdults with COVID-19 in 1 hospital in Wuhan61 (median)51.4Death or progression10.8
Luo, 202041ChinaAdults with COVID-19 with a clinical outcome in 1 hospital in Wuhan57 (median)50.3Death28.2
Petrilli, 202042United StatesAdults with laboratory confirmed critical COVID-19 in 1 hospital in New York City54 (median)49.5Composite of ICU, mechanical ventilation, discharge to hospice or death.24.3
Wu, 202043ChinaAdults with COVID-19 pneumonia in 1 hospital in Wuhan51 (median)63.7ARDS21.9
Li, 202044ChinaAdults with laboratory confirmed severe COVID-19 infection57 (median)58Death14.7
Jang, 202045KoreaAdults with COVID-19 hospitalized at a tertiary hospital in Daegu, Korea56.9 (mean)43.6Compositive of ARDS, ICU care, or death7.3
Xu, 202046ChinaAdults with laboratory-confirmed COVID-19 admitted to 16 tertiary hospitals from 8 provinces in China46.1 (mean)54Composite of death, ICU, or requiring mechanical ventilation.4.7
Zhou, 202047ChinaAdults with laboratory-confirmed COVID-19 collected from 47 locations in Sichaun43 (median)56.6Vasopressors or respiratory failure + 3 of: respiratory rate >30, PaO2/FIO2 ≤250 mm Hg, infiltrates, confusion, BUN ≥20 mg/dL, leukopenia, hypothermia, thrombocytopenia, or hypotension.NR
Hou, 202048ChinaAdults with laboratory-confirmed COVID-19 hospitalized at Beijing hospitals50.9 (median)43.6Progression defined as having a clinically advanced type of COVID-19, ICU admission, or death during hospitalization5.0
Zhang, 202049ChinaAdults with laboratory-confirmed COVID-19 in 1 hospital in Wuhan, China38.0 (median)41.4Disease deterioration including the transfer to ICU and death13.5
Liu, 202050ChinaAdults with laboratory-confirmed COVID-19 in 1 hospital in Wuhan, China65.5 (median)35.0Severe disease defined as having shortness of breath, RR ≥30 bpm, O2 sat ≤93%, PaO2/FIO2 ≤ 300 mm Hg, and progression on imagingNR
Zhu, 202051ChinaAdults with confirmed COVID-19 at 1 hospital in Zhejiang, China50.9 (mean)35.4Severe disease defined as shortness of breath, RR ≥30 bpm, O2 sat ≤93%, PaO2/FIO2 ≤300 mm Hg, or lesion progressionNR
Hu, 202052ChinaAdults with laboratory-confirmed critical COVID-19 in 1 hospital in Wuhan, China60.8 (mean)50.9Death18.0
  • COVID-19, coronavirus 2019; CT, computed tomography; RR, respiratory rate; O2 sat, oxygen saturation; BUN, blood urea nitrogen; ICU, intensive care unit; ARDS, acute respiratory distress syndrome.